Immediate Impact

63 standout
Sub-graph 1 of 23

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
4 intermediate papers

Works of Xavier Palard being referenced

Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01).
2020
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
2017

Author Peers

Author Last Decade Papers Cites
Xavier Palard 199 225 184 24 475
Michael Chan 138 115 278 25 519
Remy Lim 219 49 160 16 421
Yukinobu Yagyu 226 173 200 30 569
Yunli Yang 128 241 167 20 432
A Thalhammer 126 42 237 30 489
Carlo Gazzera 77 296 150 41 555
Lieven Van Hoe 321 53 140 22 555
Shintaro Shirai 52 188 173 40 548
Stefano Bracci 142 51 286 31 433
Anthony Goh 269 311 177 29 546

All Works

Loading papers...

Rankless by CCL
2026